参考文献/References:
[1] VAYNE-BOSSERT P,AFSHARIMANI B,GOOD P,et al.Interventional options for the management of refractory cancer pain——what is the evidence?[J].Support Care Cancer,2016,24(3):1429-1438.
[2] 毛鹏,郑春英,樊碧发.可植入鞘内药物输注系统置换术后出现吗啡戒断症状1例[J].中国疼痛医学杂志,2019,25(11):879-880.
[3] 罗秀英,万丽.重度癌痛患者鞘内植入镇痛装置居家管理的可行性分析[J].中华疼痛学杂志,2021,17(5):477-483.
[4] 袁明,杜海娜,王南瑶,等.氢吗啡酮PCA治疗晚期结直肠癌腹部难治性癌痛的临床观察[J].实用肿瘤杂志,2022,37(3):263-266.
[5] DIDIER B,ELISABETH L,IVAN K.Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer.[J].Pain,2017,158(6):1118-1125.
[6] GABRIEL C.Pancreatic cancer related pain:review of pathophysiology and intrathecal drug delivery systems for pain management[J].Pain Physician,2021,24(5):E583-E594.
[7] 张励才.麻醉解剖学[M].北京:人民卫生出版社,2016:222.
[8] 杨敏,刘朝晖,王志杰,等.分期呼吸训练在高位脊髓损伤患者肺康复护理中的应用[J].中国实用护理杂志,2021,37(27):2134-2139.
[9] 贾宏彬,宗健,孙含哲,等.远程无线自控鞘内镇痛系统在晚期癌痛患者的疗效观察[J].临床麻醉学杂志,2013,29(7):672-674.
[10]逯晓蕾,周红俊,刘根林,等.颈髓损伤后血压和心率变化的有关研究[J].中国康复理论与实践,2014,20(2):153-155.